cutaneous squamous cell carcinoma;Moffitt Cancer Center;non-melanoma skin cancer;topical cancer prevention;Skin Cancer
-
Health News
Novel Drug, NFX-179, Inhibits MEK Activity, Prevents Cutaneous Squamous Cell Carcinoma Development
[ad_1] Newswise — TAMPA, Fla. — Cutaneous squamous cell carcinoma is the second most common type of skin cancer in…
Read More »